41317-93-5Relevant academic research and scientific papers
Compound for treating or preventing hepatopathy (by machine translation)
-
Paragraph 0253-0254; 0255, (2019/10/01)
The invention discloses a compound, an optical isomer or a pharmaceutically acceptable salt, an optical isomer or a pharmaceutically acceptable salt thereof for treating or preventing hepatopathy, and the compound, optical isomer or pharmaceutically acceptable salt thereof can be applied to the preparation of a medicine for treating or preventing liver diseases. (by machine translation)
Unexpected formation of aryl dialkyl carbinol as a side product from the reaction of methoxyarylaldehydes with Grignard reagents
Sharma, Anuj,Joshi, Bhupendra P.,Singh, Narendra P.,Sinha, Arun K.
, p. 847 - 851 (2007/10/03)
In the attempted formation of secondary aryl alkyl carbinols from the reaction of methoxyarylaldehydes with Grignard reagents, aryl dialkyl carbinols were formed as unexpected side products. A mechanism for their formation is proposed.
An effective system to synthesize hypolipidemic active α-asarone and related methoxylated (E)-arylalkenes
Sharma, Anuj,Joshi, Bhupendra P.,Sinha, Arun K.
, p. 2231 - 2235 (2007/10/03)
Methoxylated (E)-arylalkenes (1a-1k) were prepared in two steps by an improved Grignard reaction comprising the reverse addition of alkylmagnesium bromide to benzaldehydes (2a-2k) in anhydrous ether and toluene into arylalkanols (3a-3k) in high yield, followed by dehydration with silica gel under microwave irradiation for 3-12 min, depending upon the substituents attached to the aromatic ring to afford hypolipidemic active α-asarone (1a) and related methoxylated (E)-arylalkenes (1b-1k).
Synthesis and hypolipidemic activity of modified side chain α-asarone homologues
Cruz,Garduno,Salazar,Martinez,Jimenez-Vazquez,Diaz,Chamorro,Tamariz
, p. 535 - 544 (2007/10/03)
A series of homologues of α-asarone (1), containing variable size and functionality on the side chain attached to the aromatic ring, has been subjected to a study of structure-activity relationship. For most of the prepared derivatives, either with a carbonyl (8a-8e), a hydroxy group (9a-9e), or with a conjugated double bond (10a-10d), significant effects on serum lipoprotein cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides were displayed. The results showed an enhancement of the hypocholesterolemic activity as the length of the chain is decreased. Theoretical conformational and electrostatic potential analyses of 1 and olefins 10 suggest unfavorable steric interactions in the bulky superior side-chain homologues as the deactivating biological effect.
